← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2011Last known activity
Jan 20, 2026
Timeline
1920s
- Jan 1, 1923
First People's Hospital of Hangzhou— Founded
Drugs by trial phase (64 distinct, 49 trials)
Phase 4 (13 own, 0 via acquisition)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (14 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (25 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma of Lung
- Aspergillosis
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Choledocholithiasis
- Colorectal Neoplasms
- Dwarfism, Pituitary
- Endocrine System Diseases
- Esophageal Neoplasms
- Invasive Pulmonary Aspergillosis
- Lung Neoplasms
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Poisoning
- Pulmonary Aspergillosis
- Recurrence
Recent trials (50)
- NCT07266168CollaboratorN/AJan 20, 2026
- NCT07202559CollaboratorN/ADec 1, 2025
- NCT07242443Lead sponsorPhase 4Nov 20, 2025
- NCT07114107CollaboratorN/AAug 31, 2025
- NCT07242456Sponsor investigatorPhase 2/Phase 3Feb 17, 2025
- NCT07242456Lead sponsorPhase 2/Phase 3Feb 17, 2025
- NCT06770309Sponsor investigatorN/AJan 2, 2025
- NCT06770309Lead sponsorN/AJan 2, 2025
- NCT06538883CollaboratorN/AAug 1, 2024
- NCT06430190Sponsor investigatorN/AJul 31, 2024
- NCT06430190Lead sponsorN/AJul 31, 2024
- NCT06765005OfficialPhase 1/Phase 2Jul 19, 2024
- NCT06867315CollaboratorN/AMay 29, 2024
- NCT06224738Sponsor investigatorEarly Phase 1Mar 1, 2024
- NCT06224738Lead sponsorEarly Phase 1Mar 1, 2024
Details
- Founded
- Hangzhou, CN Jan 1, 1923
- Last known activity
- Jan 20, 2026